Indications and usage:Indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter, where elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss.

New pharmaceutical form

Tablets, capsules

Price

$0

Price

$70-$1100

Side effects

None, as there is no chemical component

Side effects

Stomach upset

Nausea

Diarrhea

Dizziness

Back pain

Hair loss

Cough

Contraindications:

None, as there is no chemical component

Contraindications:

Ursosan will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. Hence, patients with such stones are not candidates for Ursosan therapy.

The essence of the “Emission” project is the possibility to transmit emission (properties) of organic and inorganic substances and biological objects remotely via communication lines using Internet addressing system.

Authors of the invention: Ph.D. Biology, Candidate of Chemical Sciences, Kuznetsova Irina and Ph.D. Medicine Evgeny Maevsky. AT300 was developed on the basis of the Russian Scientific-Research Institute of Hematology and Transfusion Medicine, St. Petersburg.

Dissymetric therapy (anisotropizing) tinctorial therapy (DST) – is an innovative method of oncological diseases treatment. It is based on the theory of Professor Kutushov about the causes of cancer and it's development.